3
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Failure to Detect Antideoxyribonucleic Acid Antibody in Graves' Disease in Caucasians

, , , , , , , , , , , & show all
Pages 191-198 | Published online: 07 Jul 2009

References

  • Katakura M, Yamada T, Aizawa T, Hiramatsu K, Yukimura Y, Ishihara M, Takasu N, Maruyama K, Kameko M, Kanai M. Kobayashi I Presence of antideoxyribonucleic acid antibody in patients with hyperthyroidism of Graves' disease. J Clin Endocrinol Metab 1987; 64: 405
  • Shewring G, Smith BR. An improved radioreceptor assay for TSH receptor antibodies. Clin Endocrinol (Oxf) 1984; 17: 409
  • Wilson R, McKillop J H, Pearson D W, Cuthbert G F, Thomson JA. Relapse of Graves' disease after medical therapy: Predictive value of thyroidal Technetium-99 m uptake and serum thyroid stimulating hormone receptor antibody levels. J Nucl Med 1985; 26: 1024
  • Webb J, Whaley K. Evaluation of the native DNA binding assay for DNA antibodies in systemic lupus erythematosus and other connective tissue diseases. Med J Aust 1974; 2: 324
  • Aarden L A, De Groot E R, Feltkamp T EW. Immunology of DNA III. Crithidia luciliae, a simple substrate for the determination of anti-ds DNA with the immunoflorescence technique. Ann NY Acad Sci 1975; 254: 505
  • Baethge B A, Levine S N, Wolf RE. Antibodies to nuclear antigens in Graves' disease. J Clin Endocrinol Metab 1988; 66: 485
  • Burger A, Dinichert D, Nicod P, Jenny M, Lemarchaud-Beraud T, Vallotton MB. Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxine and thyrotropin. J Clin Invest 1976; 58: 255–9
  • Martino E, Safran M, Aghini-Lombardi F, Rajatanavin R, Lenziardi M, Fay M. Environmental iodine intake and thyroid disfunction during chronic amiodarone therapy. Ann Intern Med 1984; 101: 28–34
  • Alves L E, Rose E P, Cahill TB. Amiodarone and the thyroid. Ann Intern Med 1985; 102: 412
  • Smyrk T C, Goellner J R, Brennan M D, Carney JA. Pathology of the thyroid in amiodarone-associated thyrotoxicosis. Am J Surg Pathol 1987; 11: 197–204
  • Martino E, Aghini-Lombardi F, Mariotti S, Bartalena L, Lenziardi M, Ceccarelli C. Amiodarone induced hypothyroidism: risk factors and follow-up in 28 cases. Clin Endocrinol 1987; 26: 227–38
  • Monteiro E, Galvao-Teles A, Santos M L, Mourao L, Correia M J, Lopo Tuna J. Antithyroid antibodies as an early marker for thyroid disease induced by amiodarone. Brit Med J 1986; 292: 227–8
  • Safran M, Martino E, Aghini-Lombardi F, Bartalena L, Balzano S, Pinchera A. Effect of amiodarone on circulating antithyroid antibodies. Brit Med J 1988; 297: 456–57
  • Weetman A P, Bhandal S K, Burrin J M, Robinson K, McKenna W. Amiodarone and thyroid autoimmunity in the United Kingdom. Brit Med J 1988; 297: 33
  • Foresti V, Carini L, Lovagnini-Scher C A, Parisio E, Scolari N. Amiodarone-induced thyroid disfunction: diagnostic role of free serum hormone levels and pathogenetic significance of antithyroid antibodies. Int J Clin Pharm Res 1986; 6: 241–7
  • Rabinowe S L, Larsen P R, Antman E M, George K L, Friedman P L, Jakson RA. Amiodarone therapy and autoimmune thyroid disease. Increase in a new monoclonal antibody-defined T cell subset. Am J Med 1986; 81: 53–7
  • Lutz H U, Bussolino F, Flepp R, Fasler S, Stammler P, Kazatchkine M D, Arese P. Naturally occuring anti-band-3 antibodies and complement together mediate phagocytosis of oxidatively stressed human erythrocytes. Proc Natl Acad Sci USA 1987; 84: 7368–7372
  • Berti G, Govoni M. Rat antibodies to spectrin, the principal inner component of erythrocyte membrane. Immunochemical studies after SDS-gel electrophoresis. Boll ist sieroter milan 1986; 65: 309–318
  • Williamson P, Algarin L, Bateman J, Choe H R, Schlegel RA. Phospholipid asymmetry in human erythrocyte ghosts. J Cell physiol 1985; 123: 209–214
  • Wiener E, Hughes-Jones N C, Irish W T, Wickramasinghe SN. Elution of antispectrin antibodies from red cells in homozigous β-thalassemia. Clin exp Immunol 1986; 63: 680–686
  • Lutz H U, Flepp R, Stammler P, Baccala R. Red cell associated, naturally occuring anti-spectrin antibodies. Clin exp Immunol 1987; 67: 674–676

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.